Clin2
NCT07081880Possibly a fitRecruiting

Understanding SAPHO syndrome: genetics and immune response

SAPHO Syndrome

Treatments studied

Part of Bones, joints & muscles clinical trials.

This study looks at the causes of SAPHO syndrome—a rare condition that affects the skin, bones, and joints. Researchers want to understand how genes and the immune system play a role, which may help improve future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be 18 years or older.
  • You must have been diagnosed with SAPHO syndrome (a rare condition that affects the skin, bones, and joints).
  • Your weight must be over 35 kilograms (about 77 pounds).
  • You must have health insurance that is accepted in France.
  • You must be able to speak and understand French.
  • You must agree to take part in the study and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07086599Recruiting
Sleep problems in psoriatic arthritis and SAPHO syndrome

This study looks at sleep problems in people with psoriatic arthritis or SAPHO syndrome. Participants will stay in the hospital for special sleep tests to understand their sleep issues better.

Paris
NCT06011889Recruiting· Phase 2/Phase 3
Etanercept for treating SAPHO syndrome

This study tests if etanercept, a biologic drug that targets inflammation, safely reduces pain and disease activity in people with SAPHO syndrome.

Warsaw, Masovian Voivodeship
NCT07157683Not yet recruiting
Biomarker study for systemic histiocytosis

This trial aims to find biological markers in people with systemic histiocytosis by analyzing blood or tissue samples. It may help better understand and manage the disease.

Paris
NCT05290363Recruiting
Studying a blood signal in active spondyloarthritis

This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.

Créteil
NCT06735625Recruiting
AHSP as a biomarker for sickle cell disease

This study looks at a substance in the blood called AHSP to see if it can help track sickle cell disease. It compares people with sickle cell disease (SS or Sβ0 type) to people without it, to better understand the condition.

Saint-Denis
NCT06742073Recruiting
Study of H syndrome and inflammation

This study looks at the link between H syndrome and related health issues, such as inflammation or histiocytosis (a type of immune cell disorder). It helps researchers learn more about how this rare genetic condition affects the body.

Petah Tikva

Hear when a new SAPHO Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.